The 20th Annual Academic Symposium at The Warren Alpert Medical School will go down as its biggest yet, with over 150 research posters on display featuring disciplines ranging from infectious diseases to health policy and education.
At the start of his keynote address that retraced his career path into biostatistics, Jeremy Warner, MD, MS, FAMIA, FASCO, professor of medicine and of biostatistics, shared his admiration of the event and its student presenters, and wished he had the chance to participate during his own early research years.
“I don’t think we had a symposium like this,” he said. “I wish we did.”
Warner shared that his career didn’t initially start off in biostatistics, but instead diverged while working on his hematology and medical oncology fellowship at Beth Israel Deaconess Medical Center in Boston. Institutional challenges kept him from performing his research in 2010, including systemic reviews and literature research. However, this led him to an opportunity to audit a biomedical informatics class.
Despite being only tangentially familiar with the concept, Warner continued down this path and his interest grew. He used this experience to emphasize what he wanted as his presentation’s first takeaway: how pathways always look clearer in the rearview mirror.
“In going from point A to point B, when you’re actually doing it, it’s very complicated. It’s often unexpected,” Warner said. “When you get to point B and you look back, you can reconstruct that as a straight line.”
He moved ahead another decade to February 2020, when he helped with a patient who died of a mysterious case of acute respiratory distress syndrome while recovering from an acute myeloid leukemia induction. In hindsight, Warner believes this may be one of the first COVID deaths in the nation. A call for collaboration on Twitter a month later by Aakash Desai, Assistant Professor of Medicine at the O'Neal Cancer Center, led to him playing a major role in the formation of the Covid-19 & Cancer Consortium (CCC19).
“Not only did this come about very quickly, but we ended up being as of then—and I think still—the largest registry of cancer and COVID cases by some order of magnitude,” he said.
That consortium supported his second takeaway for attendees: the need to “pay it forward.” He offered a simple formula of reviewing two or more papers for every paper submitted, and reviewing three or more grants for each grant submitted. He also emphasized exploring opportunities to sponsor other researchers.
“That’s how our community works,” Warner said. ”You should really consider how your scientific work is built upon other people’s volunteer time.”
As he discussed one of his final takeaways—how patients are always at the center of their work—Warner pointed out that electronic health records don’t always capture all vital information, like social determinants of health. A challenge for informatics going forward will be how to account for data that is impacting patients but can’t easily be mined.
Three students were selected to give oral presentations of their work. Nathalia Beller MD'29 discussed her research examining the associations between age-dependent ASPECTS (Alberta Stroke Program Early CT Score) thresholds and patient outcomes following the use of mechanical thrombectomy to treat acute ischemic stroke. Bhavya Chatragadda MD'29 presented preliminary findings in a randomized trial using music therapy to reduce patients’ anxiety during transcatheter aortic valve replacements. Joanne Lee '25 MD'29 presented research into the role mutations in DEAF-1 play in human neurological structures.
Among the poster presentations was Della Tsivor '25 MD'29, whose research examined the baseline quality of life in children with sickle cell anemia prior to their treatment with hydroxyurea (HU). The research was based on a clinical trial that examined the use of HU for patients in Luanda, Angola, for patients aged 6 months to 12 years old. Their analysis showed that there was severe impairment to their quality of life and moderate impairment to the quality of life of the patients and their families prior to starting treatment. Tsivor, who is from Ghana, said she was struck by the disproportionate amount of sickle cell disease patients in Sub-Saharan Africa and felt a personal connection to the research. She also found a lecture during her hematology block by Patrick McGann, MD, PhD, professor of medicine and of pediatrics, to be inspirational. McGann was the principal investigator.
“It caught my attention and made me feel like this is the kind of doctor I wanted to emulate,” she said.
Ann L. Kim MD'29 shared research into the characteristics of wound care among adults with drug use-associated wounds in Rhode Island. The research team found that antibiotics were the most common treatment, and treatment needs for patients varied wildly. Kim said she studied substance use disorders and their comorbidities in her gap years, and the research presented the opportunity to learn more.
“It’s a patient population that I haven’t interfaced with, so I wanted to learn about how we can provide the best care for them," Kim said.
Marisol Pacheco MD'29 and her team offered research that hit close to home for many in the Providence area. Her presentation examined how the December 2023 closure of the westbound lanes of the Washington Bridge impacted ambulance transport services to Rhode Island Hospital from areas east of the bridge. The study found no change in times across about 8,000 trips from hubs farther away from the bridge, but those in the urban core around the bridge like East Providence, Seekonk, and Rehoboth, saw "significant" increases in transportation times.
Pacheco, who is in the Primary Care Population Medicine Program, said she was drawn to the idea of studying the bridge closure from her own interest in emergency medicine and trauma services.
“I really want to learn about the populations I’m practicing medicine with and how they’re being directly affected, so if I can do research to help out, I’d like to use my resources to give back,” Pacheco said.